The post-market Viraleze trial failed to achieve it’s primary endpoint.
I know this is an uncomfortable reality for you but you have to accept it and move on.
So Starpharma have in the past blamed the FDA, the TGA, the MHRA, Mundipharma, SSL International, AstraZeneca, other partners, regulators, shorters, Covid, newer modern drugs, and market conditions for their woes.
But let me get this straight, Starpharma and rusted on sycophants are now blaming, wait for it … the patients ?!?!
OMG. Hahaha.
That’s it. There’s no more. This company has literally run out of excuses. It has to cut the crap and start delivering.
The post-market Viraleze trial failed to achieve it’s primary...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |